AF and VTE: Global Considerations in the Evolving Space of Real-World Data
Renato D. Lopes, MD, MHS, PhD
Valeria Caso, MD, PhD
Alexander T. Cohen, MD, MBBS
Optimizing AAV Outcomes: Maintenance Therapies
Bernhard Hellmich, MD
Silke R. Brix, MD, MRCP, SCPR
Patient Case Study: Obesity
Implementing the SOC Induction Therapies in AAV
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Andreas Kronbichler, MD
Patient Case Study: Elderly
Patient Case Study: Cancer-Associated Thrombosis
Don't Miss It! Rapid & Accurate AAV Diagnosis
Trade off: Ischemic/Thrombotic vs Bleeding
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Managing Patients With AAV in the Rheumatology Clinic
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
Elevating Care for Patients With Severe Renal Disease in AAV
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Setting the Stage of Real-World Data vs RCT
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.